INTRODUCTION
The Framingham Eye Study and the Baltimore Eye Survey revealed that 4-7% of people aged ≥40 years have elevated intraocular pressure (IOP). 1 2 Since the literature indicates that in patients with glaucoma, lower IOP within the normal range (10-21 mm Hg) decreases the risk of visual field deterioration in comparison with higher IOP within the normal range, 3-6 evidence of IOP reduction is necessary.
Previous studies suggest possible moderate associations between IOP elevation and cardiovascular risk factors. 7 8 Physiology clearly explains systemic hypertension as a risk factor for IOP elevation 9 10 ; however, it remains unclear whether all cardiovascular risk factors are related to IOP elevation. [11] [12] [13] [14] For example, ageing, a well-known cardiovascular risk factor, may affect IOP, but the results of previous studies have not been consistent among Caucasians, Asians and African-Americans; ageing reportedly increases IOP among European and American populations [15] [16] [17] but decreases it in Asians. [18] [19] [20] Furthermore, even if several cardiovascular risk factors have deleterious effects on IOP, it is unclear to what extent the IOP elevation can be attributed to each risk factor. 21 22 Specifically, previous studies have focused on the fact that obesity and age-related factors are highly correlated and therefore result in confounding problems that make it difficult to estimate the contribution of each cardiovascular risk factor to IOP. [23] [24] [25] Parameters indexed in the definition of metabolic syndrome are used to easily assess the lifestyles of healthy individuals and the related cardiovascular risks. Since the parameters are modified by changes in diet and physical activities, people are more likely to set their health goals at improving the parameters. 26 Recent observational studies have suggested that lifestyle and physiological factors affect IOP in healthy individuals without glaucoma 27 28 and that along with blood pressure, other metabolic syndrome parameters such as waist circumference, plasma lipid levels and plasma glucose levels may also be associated with IOP elevation. 29 30 However, the analyses have not yet solved the aforementioned controversy regarding confounding problems of the correlated explanatory parameters. In addition, they have also not quantified the level of IOP increase associated with a deterioration in the metabolic syndrome parameters. This study aimed to determine which metabolic syndrome parameters elevate IOP and to what extent in a cohort of ophthalmologically healthy individuals who had undergone medical check-ups.
METHODS

Study participants
This retrospective cohort study used data collected from residents of Yamanashi Prefecture, Japan, who visited a private healthcare centre and underwent a paid comprehensive medical check-up service between April 1999 and March 2009. To exclude the effect of ocular hypotensive therapy that would largely decrease IOP and affect the investigated associations, individuals with funduscopic findings during this period were excluded from the study. Only the first visit in a single fiscal year from April to March was considered for each participant. Hence, the maximum number of participant visits was 10 in the study data, and data from the second and subsequent visits during a fiscal year were excluded. For the cross-sectional study, we analysed data that were obtained between April 2008 and March 2009. For the longitudinal study, we included data for participants who had 3-10 visits between April 1999 and March 2009.
Measurements
During the medical check-ups, we measured IOP, waist circumference, blood pressure and serum markers of metabolic syndrome. All medical measurements were recorded between 9:00 and 12:00. Serum markers were assessed from blood samples that were collected in the morning before breakfast. IOP was measured with a non-contact tonometer (NT-3000, Nidek, Tokyo), and IOP levels in the right eyes were analysed. Blood pressure was measured on the upper right arm while the participants were seated. The baseline body mass index (BMI) was calculated as weight in kilograms divided by the square of height in metres.
Statistical analyses
To assess the relationship between metabolic syndrome and IOP in the cross-sectional study, Pearson's correlation coefficients with Bonferroni correction for multiple comparisons were calculated to determine the association between IOP and waist circumference, highdensity lipoprotein cholesterol (HDL-C) levels, triglyceride levels, systolic blood pressure (SBP), diastolic blood pressure (DBP) and fasting plasma glucose (FPG) levels.
To determine the association between IOP and the severity of metabolic syndrome in the cross-sectional study, the mean IOP levels were represented with respect to the numbers (0-5) of positive metabolic syndrome parameters according to the diagnostic criteria. The diagnostic criteria were based on the International Diabetes Federation guidelines. 31 The five identified parameters of metabolic syndrome were a waist circumference of ≥85 cm in men and ≥90 cm in women; triglyceride levels of ≥1.7 mmol/L (150 mg/dL) or specific treatment for this lipid abnormality; HDL-C levels of <1.03 mmol/L (40 mg/dL) in men and <1.29 mmol/L (50 mg/dL) in women or specific treatment for this lipid abnormality; SBP of ≥130 mm Hg, DBP of ≥85 mm Hg or treatment of previously diagnosed hypertension; and FPG levels of >5.6 mmol/L (100 mg/dL) or previously diagnosed type 2 diabetes. The Jonckheere-Terpstra trend test was used to assess the significance of the trend in IOP with respect to the numbers of positive metabolic syndrome parameters. 32 Univariate and multivariate mixed-effects models with a random intercept for participants were used to longitudinally assess the relationship between changes in IOP and metabolic syndrome parameters. 33 Since waist circumference was measured only during the past three fiscal years (2006-2008) during the observed 10-year period, it was not included in the longitudinal analyses. Before conducting the multivariate analysis, we checked the multicollinearities among all the explanatory variables, particularly between SBP and DBP, which could seriously interfere with the estimates of interest. 34 In terms of variance inflation factors ≤4, no multicollinearity was detected. 35 The used model examples for the longitudinal analyses are represented below.
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Sensitivity analyses
To confirm the longitudinal results, we performed two sensitivity analyses: (1) The first sensitivity analysis was conducted using the data in which metabolic syndrome parameters and IOP could be measured one or more times in a single fiscal year. As a result, participants had 3-20 visits between April 1999 and March 2009. (2) The second sensitivity analysis was conducted using the data for which the age of participants was restricted to 19-44 years. This was done because the data suggested that participants aged less than 45 years were more likely to be lost to follow-up, and the main longitudinal results were deduced primarily from middle-aged participants. All statistical analyses were performed using SAS statistical software (V.9.3, SAS Institute, Cary, North Carolina, USA) Descriptive statistics were reported as means and SDs; the point estimates were reported with 95% CIs. All reported p values were two-sided, and p<0.05 was considered statistically significant. Table 1 shows the characteristics of the 10 122 men and 9885 women who were included in the cross-sectional analyses and underwent medical check-ups between April 2008 and March 2009. The mean (SD) values for men were as follows: age, 54.3 (11.6) years; IOP, 12.9 (2.9) mmg; BMI, 23.4 (2.9) kg/m 2 ; waist circumference, 84.8 (7.9) cm; HDL-C levels, 1. 39 Table 2 represents Pearson's correlation coefficients for IOP in both sexes in relation to age and metabolic syndrome parameters. In men, IOP was negatively correlated with age levels and positively correlated with waist circumference, HDL-C levels, triglyceride levels, SBP, DBP and FPG levels. In women, IOP was positively correlated with waist circumference, triglyceride levels, SBP, DBP and FPG levels. Table 3 shows the means and SDs of the IOP levels stratified by the numbers of positive metabolic syndrome parameters. The analysed population in the cross-sectional study was restricted to 15 256 participants for whom data for all metabolic parameters, history and medication were available. Individuals with 0, 1, 2, 3, 4 and 5 positive metabolic syndrome parameters showed mean (SD) IOP of 12.2 (2.7), 12.6 (2.8), 12.9 (2.9), 13.3 (2.9), 13.3 (2.8) and 13.5 (2.8) mm Hg, respectively. The Jonckheere-Terpstra trend test detected statistical significance with p<0.0001 between the number of positive metabolic syndrome parameters and mean IOPs.
RESULTS
Cross-sectional study
Longitudinal study
The longitudinal study included the data of changes in measured parameters in 15 747 participants. The mean (SD) number of visits during the 10-year period among the participants of the longitudinal analyses was 4.34 (2.53) for men and 4.03 (2.42) for women. The mean (SD) follow-up duration was 1711 (929) days for men and 1705 (881) days for women. Table 4 shows the estimated coefficients, 95% CIs and p values in the mixed-effects models, analysing the relationship between the change in IOP and the changes in the metabolic syndrome parameters. After adjusting for multiple cardiovascular risk factors, the change in IOP showed negative associations with male sex and ageing and positive associations with increases in HDL-C levels, triglyceride levels, SBP, DBP and FPG levels. Sensitivity analyses Table 5 shows the results of the two sensitivity analyses:
(1) which allowed multiple measurements in a single fiscal year among the same 15 747 participants and (2) in which participant ages were restricted to 19-44 years (n=5261). In the first sensitivity analysis, the estimated coefficients for the longitudinal association between changes in metabolic syndrome parameters and IOP were almost similar to those of the original multivariate analysis. The second sensitivity analysis also suggested little differences in the estimated coefficients between the data of the younger adults and those of the total study participants.
DISCUSSION
Main findings
The cross-sectional study indicated that an increase in age was a protective factor against elevated IOP, and increases in HDL-C, triglyceride, SBP, DBP and FPG levels were risk factors for elevated IOP. The longitudinal data over 10 years revealed that ageing decreased IOP and that worsening of triglyceride levels, SBP, DBP and FPG levels elevated IOP.
Interpretation of the models
The cross-sectional and longitudinal analyses provided different interpretations of the association between metabolic syndrome and IOP. The cross-sectional study showed modest-to-moderate relationships at a single time point, independent of the units of metabolic syndrome parameters (table 2) . The cross-sectional study also exhibited a dose-response relationship of the severity of metabolic syndrome to elevated IOP (table 3) . Crude and confounder-adjusted changes in IOP per unit increase in each metabolic syndrome parameter as longitudinal associations are presented in table 4 . We believe that this observational study answered the study question regarding which metabolic syndrome parameters contribute to changes in IOP as well as the magnitude of such changes.
Results in the context of other studies
The results of this study agree with those of previous studies that described SBP 7 36 as a moderate risk factor for elevated IOP. Concerning ageing, the results have been inconsistent across populations; while results from Western populations have shown that ageing is positively correlated with IOP, 36 37 results from Asian populations have been consistent with ageing as a protective factor against high IOP. 18-20 22 23 29 38 The present longitudinal results from a Japanese population favour this hypothesis about Asians. Ageing may have the potential to exert an ocular hypotensive effect after adjusting for confounders. In terms of glycated haemoglobin levels that reflect the month-to-month plasma glucose levels, 39 other univariate longitudinal mixed-effects model analyses demonstrated that an increase of 10 mmol/mol in glycated haemoglobin levels is associated with a −0.030 mm Hg IOP change (95% CI −0.061 to 0.002, p=0.07) and that an increase of 1% in glycated haemoglobin levels is associated with a −0.032 mm Hg IOP change (95% CI −0.067 to 0.003, p=0.07).
Although an observational study indicated diabetes mellitus as a risk factor for primary open-angle glaucoma, 12 little is known about the association between high plasma glucose levels and IOP. This study, which showed a positive relationship with FPG levels and a negative relationship with glycated haemoglobin levels, did not provide a clear indication of the association between elevated plasma glucose levels and IOP. With respect to the effect of serum lipids on IOP, some previous studies have shown moderate positive correlations between serum triglyceride levels and IOP, 30 40-42 whereas another study found no association between these two factors. 43 The present results were inconclusive about the association between HDL-C levels and IOP; our results demonstrated a small cross-sectional association and a moderate longitudinal association between HDL-C levels and IOP. Since elevated total cholesterol levels can be partly attributed to elevated HDL-C levels, 44 and epidemiological studies have not yet revealed an association between IOP and serum lipids, physiological studies to investigate the presence or absence of this association would be necessary.
Possible reasons for these associations
Studies have suggested possible mechanisms for the association between cardiovascular risk factors and elevated IOP. In particular, hypertension is linked to an elevated IOP in a physiological manner; SBP, rather than DBP, elevates IOP because peaks of SBP that reach the eye can lead to ultrafiltration. [45] [46] [47] On the other hand, although epidemiological studies have reported obesity as a risk factor for increased IOP, 48 it has not been clearly explained how lifestyle-related factors elevate IOP. Although unproven, one study attributed this phenomenon observed in obese individuals to the fact that obesity produced excess intraorbital fat tissue, increased episcleral venous pressure and blood viscosity. 49 Another study in a Korean population, using insulin resistance as an index mediating all obesity-related systemic factors, indicated the necessity of further cohort studies that handle respective obesity-related parameters as independent exposure variables. 50 With respect to the high prevalence of elevated IOP that has been observed among patients with diabetes, 36 48 diabetes-related autonomic dysfunction, genetic factors and corneal stiffening may partly explain elevated IOP. 24 The mechanisms of ageing, which is a risk factor for elevated IOP in Westerners but not in Asians, may be explained by the high prevalence of obesity, hypertension and diabetes in aged Westerners. 51 52 It has been speculated that the ocular hypertensive effects of ageing in Westerners may be a result of the ocular hypertensive effects of obesity, hypertension and diabetes that surpass the actual hypotensive effects of ageing. Concerning the moderate positive association between serum triglyceride levels and IOP in this study, there has been no comparable literature. Since statins reportedly decrease the risk of openangle glaucoma, 53 individuals who had been treated with statins and had relatively low IOP in the data may have produced the observed moderate association between IOP elevation and high serum triglycerides. Whereas age, 16 African-Americans, 54 55 family history, 56 hypertension, 9 diabetes 57 and elevated IOP 58 are known risk factors for open-angle glaucoma, the previous and present studies have suggested that age is a protective factor in Asians, and hypertension 9 10 and high plasma glucose 36 48 are risk factors for elevated IOP.
Strengths and limitations
The following three factors were the strengths of this study. First, we believe that modelling IOP in relation to ageing, serum lipids, blood pressure and plasma glucose together estimated the amount of IOP attributable to lifestyle-related systemic parameters and addressed the underlying confounding problems. As shown in table 3, the increase in the severity of the metabolic syndrome resulted in a linear increase in IOP. We consider that the consistency between the cross-sectional and longitudinal results reflects the internal validities. Second, the number of participants and the follow-up period in this study were sufficient to investigate the study question. We propose that the results of the study could be extrapolated to Japanese populations. Third, the mixed-effects models in table 4 incorporated repeated measurements and could detect the longitudinal change-to-change relationships. This study has some limitations. The first is that the data included ophthalmologically healthy participants, most of whom were middle-aged or older. Although the results could be applied to ophthalmologically premedicated people, a study about the intervention of lifestyle modifications on IOP among ophthalmological patients is warranted to ensure applicability to all ophthalmological patients. In addition, since the main longitudinal regression results were deduced primarily from middle-aged individuals, the associations may not be directly applied to younger generations. However, the sensitivity analysis (2) confirmed that the associations in younger generations and those in the total population were almost similar. Another limitation is that IOP was measured using non-contact tonometry. It has been reported that IOP measured by this device is not directly comparable to IOP measured by the Goldmann applanation tonometer, the gold standard instrument. Since the difference in measurements between the Goldmann applanation tonometer and non-contact tonometry may increase with ageing, 59 IOP measurements would have been more accurate if the thicknesses of the corneas had been measured simultaneously and used to adjust the IOP measurements. This means that IOP in the present data may have been negatively biased in middle-aged or older participants. However, we believe that the ability of the mixed-effects model to estimate the change-to-change relationships minimised this systematic bias. Lastly, this study did not include actual lifestyle-related variables, such as diet, physical activities, smoking, other diseases and socioeconomic status. The study suggests that if people improve their metabolic syndrome parameters by modifying their lifestyles, their IOP will decrease; however, a study with lifestyle interventions would be necessary to confirm this suggestion.
CONCLUSION
The longitudinal studies revealed that deterioration of waist circumference, blood pressure and FPG accompany the elevation of IOP. The results also suggest that an increase in HDL-C levels accompanies an elevation of IOP; therefore, the results should be carefully interpreted, and further physiological investigations regarding serum lipids and IOP are necessary.
